Article tools
Author information

Research Article

Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.

J Bloomer, C Bruzzone, L Zhu, Y Scarlett, S Magness and D Brenner

Liver Center at The University of Alabama at Birmingham, Birmingham, Alabama 35294-0005, USA. j_bloomer@gasmac.dom.uab.edu

Protoporphyria is a genetic disorder in which a deficiency of mitochondrial ferrochelatase activity causes accumulation of protoporphyrin that produces severe liver damage in some patients. In this study, mutations of the ferrochelatase gene were examined in eight unrelated patients who had liver transplantation. RNA was prepared from liver and/ or lymphoblasts, and specific reverse transcriptase-nested polymerase chain reactions amplified and sequenced ferrochelatase cDNAs. Products shorter than normal resulted from an exon 3 deletion in three patients, exon 10 deletion in two, exon 2 deletion in one, and deletion of five nucleotides in exon 5 in one. Sequence of normal-size products revealed no other mutations. Western blot showed a reduced quantity of normal-size ferrochelatase protein in protoporphyria liver compared with normal liver (19-51%, mean 32% of normal). Levels of the mitochondrial protein F1-ATPase beta-subunit were not decreased to a similar degree. Liver ferrochelatase activity was reduced more than could be explained by the decrease in ferrochelatase protein (4-20%, mean 9% of normal). These results establish genetic heterogeneity in the most severe phenotype of protoporphyria. However, the gene mutations found share the property of causing a major structural alteration in the ferrochelatase protein.


Articles that cite this article:

Erythropoietic protoporphyria advances today, with a special tribute to the late Professor Ian Magnus
G.M. Murphy, J.L.M. Hawk
Br J Dermatol 155(3):501. doi:10.1111/j.1365-2133.2006.07471.x [CrossRef]

Liver transplantation for erythropoietic protoporphyria liver disease
Brendan M. Mcguire, Herbert L. Bonkovsky, Robert L. Carithers, Raymond T. Chung, Leonard I. Goldstein, John R. Lake, Anna S. Lok, Carol J. Potter, Elizabeth Rand, Michael D. Voigt
Liver Transpl 11(12):1590. doi:10.1002/lt.20620 [CrossRef]

Die Porphyrien: Was Dermatologen wissen sollten. . The Porphyrias: What dermatologists should know
P. Poblete Gutierrez1, T. Wiederholt1, J. Frank1, 2
H&G Zeitschrift Hautkrankheiten 77(6):265. doi:10.1046/j.1439-0353.2002.02101.x [CrossRef]

Molecular characterization of erythropoietic protoporphyria in South Africa
A.V. Corrigall, R.J. Hift, M. Parker, P.N. Meissner
Br J Dermatol 159(1):182. doi:10.1111/j.1365-2133.2008.08580.x [CrossRef]

Biochemical Abnormality in Erythropoietic Protoporphyria
Joseph R. Bloomer, Yongming Wang, Anuj Singhal, Hiba Risheg
JPGN Journal of Pediatric Gastroenterology and Nutrition 43(supplement 1):S36. doi:10.1097/01.mpg.0000226388.56612.fa [CrossRef]

Haplotype Analysis of Families with Erythropoietic Protoporphyria and Novel Mutations of the Ferrochelatase Gene
Xiuhua Wang, Lin Yang, Lisa Kurtz, Alan Lichtin, Vincent A. Deleo, Joseph Bloomer, Maureen B. Poh-fitzpatrick
J Invest Dermatol 113(1):87. doi:10.1046/j.1523-1747.1999.00637.x [CrossRef]

Haplotype Analysis in Determination of the Heredity of Erythropoietic Protoporphyria among Swiss Families
Xiaoye Schneider-yin, Urszula B. Rufenacht, Martin Hergersberg, Cecile Schnyder, Jean-Charles Deybach, Elisabeth I. Minder
J Invest Dermatol 117(6):1521. doi:10.1046/j.0022-202x.2001.01604.x [CrossRef]

A Novel Ferrochelatase Gene Mutation (IVS1-2 AC) in Erythropoietic Protoporphyria
Wook Lew
J Invest Dermatol 121(2):425. doi:10.1046/j.1523-1747.2003.12375.x [CrossRef]

Diagnosis and management of the erythropoietic porphyrias
Gillian M. Murphy
Dermatol Ther 16(1):57. doi:10.1046/j.1529-8019.2003.01609.x [CrossRef]

Molecular Studies of Liver Disease in Erythropoietic Protoporphyria
Joseph Bloomer, Yongming Wang, Anuj Singhal, Hiba Risheg
J Clin Gastroenterol 39(supplement 2):S167. doi:10.1097/01.mcg.0000155518.96629.ea [CrossRef]